Opus Genetics, Inc. IRD
4.76
(0.11)
(2.26%)
as of 25 Sep
- Market cap
- $405.2M
- P/E
- 0.0×
Follow IRD
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | 4.33 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | 31.86 | 1.73 | 3.48 | 2.89 | 8.81 |
P/FCF ratio |
— | — | — | — | — | 0.00 | 5.50 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | — | (9.81) | 2.43 | 14.57 | (4.27) | (12.72) |
P/B ratio |
— | — | — | — | — | 2.49 | 1.51 | 1.33 | 4.73 | 8.15 |
Price to Tangible BV |
— | — | — | — | — | 2.49 | 1.51 | 1.33 | 4.73 | 8.15 |
EV/Sales |
— | — | — | — | — | 17.95 | 0.68 | 0.84 | 0.16 | 5.72 |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | (1.61) | 1.92 | (14.39) | (0.07) | (2.30) |
EV/FCF |
— | — | — | — | — | (1.49) | 2.16 | (5.93) | (0.06) | (2.21) |
Quick Ratio |
10.79 | 8.30 | 4.67 | 0.16 | 5.15 | 6.42 | 15.98 | 12.73 | 3.00 | 6.05 |
Current Ratio |
11.12 | 8.70 | 5.04 | 0.19 | 5.55 | 6.76 | 17.79 | 13.35 | 3.24 | 6.43 |
Net Debt/EBITDA |
1.24 | 1.55 | 0.71 | (0.99) | 0.82 | 1.07 | (2.34) | 4.79 | 0.49 | 1.17 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 317.66% | 0.00% | 2.06% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (0.75) | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 1.06 | 0.37 | 0.24 | 0.33 |
Operating CF/Net income |
1.42 | 0.61 | 1.31 | 0.58 | 0.28 | 0.34 | 0.80 | 0.11 | 0.44 | 0.71 |
Capex/Depreciation |
0.27 | (10.90) | 0.14 | (8.33) | (184.37) | (25.00) | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (51.95%) | (149.55%) | (105.14%) | (410.87%) | 234.18% | (1,295.10%) | 52.26% | (20.77%) | (203.19%) | (449.36%) | |
| (40.60%) | (102.55%) | (64.82%) | (69.21%) | (252.95%) | (259.11%) | 47.66% | (19.40%) | (126.71%) | (113.86%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 320.34% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(48.65%) | (101.08%) | (111.73%) | 81.60% | (169.83%) | (255.12%) | 38.69% | (20.01%) | (225.02%) | (116.79%) |
Average Days of Receivables |
— | — | — | — | — | 0.00 | 11.89 | 17.74 | 118.31 | 51.29 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2,576.06% | 36.02% | 92.67% | 499.01% | 217.05% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,378.78% | 18.24% | 62.78% | 165.71% | 154.85% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 324.96% | 4.53% | 18.43% | 30.59% | 23.94% |
Graham Net Nets |
— | — | — | — | — | 0.40 | 0.66 | 0.75 | 0.20 | 0.12 |
Graham Number |
— | — | — | — | — | 0.00 | 6.50 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | (125.74%) | 23.08% | (15.31%) | (180.67%) | (40.80%) |
Free Cash Flow Yield |
— | — | — | — | — | (37.83%) | 18.19% | (4.07%) | (85.44%) | (29.46%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 2.00 | 0.88 | 0.41 | 0.23 |
Operating CF per Share |
(29.21) | (27.03) | (27.51) | (1.26) | (1.46) | (1.30) | 0.72 | (0.05) | (0.96) | (0.57) |
Capex per Share |
(0.02) | (0.13) | (0.06) | (0.01) | (0.32) | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(29.23) | (27.17) | (27.57) | (1.27) | (1.77) | (1.31) | 0.72 | (0.05) | (0.96) | (0.57) |
Cash per Share |
44.87 | 47.04 | 21.50 | 0.54 | 3.52 | 1.67 | 2.14 | 2.34 | 1.14 | 0.72 |
Shareholders Equity per Share |
37.67 | 29.40 | 15.42 | (2.66) | (2.89) | 1.50 | 2.32 | 2.31 | 0.25 | 0.25 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
37.67 | 29.40 | 15.42 | (2.66) | (2.89) | 1.50 | 2.32 | 2.31 | 0.25 | 0.25 |
Free Cash Flow |
(13.24) | (15.50) | (18.88) | (3.62) | (8.27) | (19.47) | 14.31 | (1.11) | (25.58) | (35.25) |
Working Capital |
19.04 | 24.90 | 12.75 | (7.58) | 14.48 | 22.21 | 46.23 | 49.91 | 25.32 | 42.26 |
Capital Expenditures |
(0.01) | (0.08) | (0.04) | (0.02) | (1.47) | (0.10) | — | — | — | — |
Net Current Asset Value |
16.94 | 16.62 | 10.42 | (7.58) | (13.48) | 22.21 | 46.23 | 49.91 | 6.47 | 15.15 |
EV/EBIT |
— | — | — | — | — | 0.00 | 1.51 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (9,625.30%) | 44.89% | (52.42%) | (523.40%) | (349.33%) |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
(0.36) | 0.06 | (2.56) | 0.14 | 0.57 | 0.40 | 0.67 | 0.00 | 0.04 | 0.27 |
Cash ROIC |
(35.63%) | (35.65%) | (74.94%) | 1,015.45% | (232.30%) | (40.79%) | 16.09% | (1.11%) | (69.72%) | (58.66%) |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 0.00 | 17.13 | 4.90 | 5.11 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | — | — | — | — | — | — | 1.11 | 2.24 | 2.78 |
Average Payables |
2.27 | 2.56 | 3.19 | 1.75 | 0.78 | 1.40 | 1.33 | 1.61 | 2.65 | 3.22 |
Average Assets |
22.92 | 24.67 | 22.17 | 8.91 | 9.73 | 21.88 | 37.53 | 51.47 | 45.41 | 43.55 |
Average Common Equity |
17.92 | 16.91 | 13.67 | 1.50 | (10.51) | 4.38 | 34.23 | 48.07 | 28.32 | 11.04 |
Columns are period end dates